Suicide gene therapy for plasma cell tumors

Blood

Volumn 88, Issue 6, 1996, Pages 2192-2200

  Dilber, M Siraç ^a   Abedi, Mohammad R ^b   Björkstrand, Bo ^b   Christensson, Birger ^b   Gahrton, Gösta ^b   Xanthopoulos, Kleanthis G ^b   Smith, C I Edvard ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; THYMIDINE KINASE;

ANIMAL CELL; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; GENE THERAPY; GENETIC TRANSDUCTION; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; MYELOMA; MYELOMA CELL; NONHUMAN; PLASMACYTOMA; PRIORITY JOURNAL;

EID: 0029843909     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.6.2192.bloodjournal8862192     Document Type: Article

References (44)

1. Gahrton G, Tura S, Ljungman P, Belanger C, Brandt L, Cavo M, Facon T, Granena A, Gore M, Gratwohl A, Löwenberg B, Nikoskelainen J, Reiffers JJ, Samson D, Verdonck L, Volin L: Allogeneic bone marrow transplantation in multiple myeloma. N Engl J Med 325:1267, 1991
2. Dunbar CE, Nienhuis AW: Multiple myeloma. New approaches to therapy. JAMA 269:2412, 1993
3. Alexanian R, Dimopoulos MA: Management of multiple myeloma. Semin Hematol 32:20, 1995
4. Bosma GC, Custer RP, Bosma MJ: A severe combined immunodeficiency mutation in the mouse. Nature 301:527, 1983
5. McCune JM, Namikawa R, Kaneshima H, Shultz LD, Lieberman M, Weissman IL: The SCID-hu mouse: Murine model for the analysis of human hematolymphoid differentiation and function. Science 241:1632, 1988
6. Mosier DE, Gulizia RJ, Baird SM, Wilson DB: Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 335:256, 1988
7. Cannon MJ, Pisa P, Fox RI, Cooper NR: Epstein-Barr virus induces aggressive lymphoproliferative disorders of human B cell origin in SCID/hu chimeric mice. J Clin Invest 85:1333, 1990
8. Ghetie MA, Richardson J, Tucker T, Jones D, Uhr JW, Vitetta ES: Disseminated or localized growth of a human B-cell tumor (Daudi) in SCID mice. Int J Cancer 45:481, 1990
9. Mosier DE, Picchio GR, Baird SM, Kobayashi R, Kipps TJ: Epstein-Barr virus-induced human B-cell lymphomas in SCID mice reconstituted with human peripheral blood leukocytes. Cancer Res 52:5552s, 1992 (suppl)
10. Abedi MR, Christensson B, Al-Masud S, Hammarström L, Smith CIE: Gammaglobulin modulates growth of EBV-derived B-cell tumors in SCID mice reconstituted with human lymphocytes. Int J Cancer 55:824, 1993
11. Kamel-Reid S, Letarte M, Sirard C, Doedens M, Grunberger T, Fulop G, Freedman MH, Phillips RA, Dick JE: A model of human acute lymphoblastic leukemia in immune-deficient SCID mice. Science 246:1597, 1989
12. Kamel-Reid S, Letarte M, Doedens M, Greaves A, Murdoch B, Grunberger T, Lapidot T, Thorner P, Freedman MH, Phillips RA, Dick JE: Bone marrow from children in relapse with pre-B acute lymphoblastic leukemia proliferates and disseminates rapidly in scid mice. Blood 78:2973, 1991
13. Huang YW, Richardson JA, Tong AW, Zhang BQ, Stone MJ, Vitetta ES: Disseminated growth of a human multiple myeloma cell line in mice with severe combined immunodeficiency disease. Cancer Res 53:1392, 1993
14. Tong AW, Huang YW, Zhang BQ. Netto G, Vitetta ES, Stone MJ: Heterotransplantation of human multiple myeloma cell lines in severe combined immunodeficiency (SCID) mice. Anticancer Res 13:593, 1993
15. Bellamy WT, Odeleye A, Finley P, Huizenga B, Dalton WS, Weinstein RS, Hersh EM, Grogan TM: An in vivo model of human multidrug-resistant multiple myeloma in SCID mice. Am J Pathol 142:691, 1993
16. Feo-Zuppardi FJ, Taylor CW, Iwato K, Lopez MH, Grogan TM, Odeleye A, Hersh EM, Salmon SE: Long-term engraftment of fresh human myeloma cells in SCID mice. Blood 80:2843, 1992
17. Ahsmann EJ, van Tol MJ, Oudeman-Gruber J, Lokhorst H, Uytdehaag FG, Schuurman HJ, Bloem AC: The SCID mouse as a model for multiple myeloma. Br J Haematol 89:319, 1995
18. Lashford L: Gene therapy for cancers. Arch Dis Child 71:485, 1994
19. Schmidt-Wolf G, Schmidt-Wolf IG: Human cancer and gene therapy. Ann Hematol 69:273, 1994
20. Gilboa E, Lyerly HK, Vieweg J, Saito S: Immunotherapy of cancer using cytokine gene-modified tumor vaccines. Semin Cancer Biol 5:409, 1994
21. Tepper RI, Mule JJ: Experimental and clinical studies of cytokine gene-modified tumor cells. Hum Gene Ther 5:153, 1994
22. Culver KW, Ram Z, Wallbridge S, Ishii H, Oldfield EH, Blaese RM: In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 256:1550, 1992
23. Ram Z,Culver KW, Walbridge S, Blaese RM, Oldfield EH: In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats. Cancer Res 53:83, 1993
24. Vile RG, Hart IR: Use of tissue-specific expression of the herpes simplex virus thymidine kinase gene to inhibit growth of established murine melanomas following direct intratumoral injection of DNA. Cancer Res 53:3860, 1993
25. Smythe WR, Hwang HC, Amin KM, Eck SL, Davidson BL, Wilson JM, Kaiser LR, Albelda SM: Use of recombinant adenovirus to transfer the herpes simplex virus thymidine kinase (HSVtk) gene to thoracic neoplasms: an effective in vitro drug sensitization system. Cancer Res 54:2055, 1994
26. Chen SH, Shine HD, Goodman JC, Grossman RG, Woo SL: Gene therapy for brain tumors: Regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Proc Natl Acad Sci USA 91:3054, 1994
27. Yoshida K, Kawami H, Yamaguchi Y, Kuniyasu H, Nishiyama M, Hirai T, Yanagihara K, Tahara E, Toge T: Retrovirally transmitted gene therapy for gastric carcinoma using herpes simplex virus thymidine kinase gene. Cancer 75:1467, 1995
28. Heyman RA, Borrelli E, Lesley J, Anderson D, Richman DD, Baird SM, Hyman R, Evans RM: Thymidine kinase obliteration: Creation of transgenic mice with controlled immune deficiency. Proc Natl Acad Sci USA 86:2698, 1989
29. Morgan RA, Cometta K, Anderson WF: Applications of the polymerase chain reaction in retroviral-mediated gene transfer and the analysis of gene-marked human TIL cells. Hum Gene Ther 1:135, 1990
30. Culver KW, Blaese RM: Gene therapy for cancer. Trends Genet 10:174, 1994
31. Abedi MR, Christensson B, Islam KB, Hammarström L, Smith CIE: Immunoglobulin production in severe combined immunodeficient (SCID) mice reconstituted with human peripheral blood mononuclear cells. Eur J Immunol 22:823, 1992
32. Moolten FL: Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: Paradigm for a prospective cancer control strategy. Cancer Res 46:5276, 1986
33. Moolten FL, Wells JM, Heyman RA, Evans RM: Lymphoma regression induced by ganciclovir in mice bearing a herpes thymidine kinase transgene. Hum Gene Ther 1:125, 1990
34. Chen SH, Chen XHL, Wang TB, Kosai KI, Finegold MJ, Rich SS, Woo SLC: Combination gene therapy for liver metastasis of colon carcinoma in vivo. Proc Natl Acad Sci USA 92:2577, 1995
35. Freeman SM, Abboud CN, Whartenby KA, Packman CH, Koeplin DS, Moolten FL, Abraham GN: The "bystander effect": Tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res 53:5274, 1993
36. Vile RG, Nelson JA, Castleden S, Chong H, Hart IR: Systemic gene therapy of murine melanoma using tissue specific expression of the HSVtk gene involves an immune component. Cancer Res 54:6228, 1994
37. Tiberghien P, Reynolds CW, Keller J, Spence S, Deschaseaux M, Certoux JM, Contassot E, Murphy WJ, Lyons R, Chiang Y, Hervé P, Longo DL, Ruscetti FW: Ganciclovir treatment of herpes simplex thymidine kinase-transduced primary T lymphocytes: An approach for specific in vivo donor T-cell depletion after bone marrow transplantation? Blood 84:1333, 1994
38. Bi WL, Parysek LM, Warnick R, Stambrook PJ: In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSVtk retroviral gene therapy. Hum Gene Ther 4:725, 1993
39. Barba D, Hardin J, Sadelain M, Gage FH: Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors. Proc Natl Acad Sci USA 91:4348, 1994
40. Schuler W, Schuler A, Bosma MJ: Defective V-to-J recombination of T cell receptor gamma chain genes in scid mice. Eur J Immunol 20:545, 1990
41. Dorshkind K, Pollack SB, Bosma MJ, Phillips RA: Natural killer (NK) cells are present in mice with severe combined immunodeficiency (scid). J Immunol 134:3798, 1985
42. Kumar V, Hackett JJ, Tutt MM, Garni-Wagner BA, Kuziel WA, Tucker PW, Bennett M: Natural killer cells and their precursors in mice with severe combined immunodeficiency. Curr Top Microbiol Immunol 152:47, 1989
43. Westendorf JJ, Lammert JM, Jelinek DF: Expression and function of Fas (APO-1/CD95) in patient myeloma cells and myeloma cell lines. Blood 85:3566, 1995
44. Björkstrand B, Dilber MS, Smith CIE, Gahrton G, Xanthopoulos KG: Retroviral-mediated gene transfer into human myeloma cells. Br J Haematol 88:325, 1994